BTIG analysts reiterated a Buy rating on Boston Scientific Corporation (NYSE:BSX) on February 09, 2026.
Boston Scientific Corporation operates in the Healthcare sector. The stock currently trades at $74.12 with a market capitalization of $136.0B.
reiterateNYSE:BSX
BTIG Reiterates Buy Rating on Boston Scientific Corporation (BSX)
BTIG analysts reiterated a Buy rating on Boston Scientific Corporation (NYSE:BSX) on February 09, 2026. Boston Scientific Corporation operates in the Healthcare sector. The stock…
